2025 annual financial data
Agios Pharmaceuticals 2025 Operating margin
Agios Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -873.87%.
Operating income was -472,132,000 USD and net income was -412,781,000 USD.
Operating cash flow was -372,977,000 USD.
Get free Agios Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 54,028,000 USD
- Operating income
- -472,132,000 USD
- Net income
- -412,781,000 USD
- Operating cash flow
- -372,977,000 USD